Type	Name	Date
Indenture	Indenture, between PDL, BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee	09/17/2019
Indenture	Supplemental Indenture, by and between PDL BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee	09/17/2019
Securities purchase agreement	Securities Purchase Agreement	04/11/2019
Indenture	Indenture between the Company and The Bank of New York Mellon Trust Company, N.A, as trustee	11/28/2016
Indenture	Supplemental Indenture between the Company and The Bank of New York Mellon Trust Company, N.A, as trustee	11/28/2016
Credit agreement	Credit Agreement, among PDL BioPharma, Inc., as borrower, the lenders from time to time party thereto and Royal Bank of Canada, as administrative agent	04/01/2015
Indenture	Indenture between the Company and The Bank of New York Mellon Trust Company, N.A, as trustee	02/12/2014
Indenture	Supplemental Indenture between the Company and The Bank of New York Mellon Trust Company, N.A, as trustee	02/12/2014
Credit agreement	Credit Agreement, among PDL BioPharma, Inc., as borrower, the lenders from time to time party thereto and Royal Bank of Canada, as administrative agent	10/30/2013
Indenture	Indenture, between PDL BioPharma, Inc. and The Bank of New York Mellon Trust Company, N.A, as trustee	01/06/2012
Indenture	Supplemental Indenture, between the Company and The Bank of New York Mellon Trust Company, N.A, as trustee	05/16/2011
Indenture	Indenture between QHP Royalty Sub LLC and U.S. Bank National Association as trustee	11/06/2009